已核实 DOI PubMed 相关产品: 0

Biocompatible and long-acting polyphosphate inhibitors for the diagnosis and treatment of thrombosis and thromboembolism

Journal 2026 · IF 6.7 · 发表于 2026 年 7 月 3 日
作者: Xinyi Xu,Panpan Ji,Chao Li,Ruoyu Chen,Yang Zhou,Juhong Wu,Nannan Zeng,Yanling Chen,Longguang Jiang,Cai Yuan,Mingdong Huang,Peng Xu,Linsen Li
阅读全文 在 PubMed 查看

摘要

Cationic PolyP inhibitors (PEI and PLL) suffer from vascular toxicity and rapid renal clearance. • Conjugation with Pc improved the duration of action and biosafety of PolyP inhibitors. • The antithrombotic activities of PolyP inhibitors were mediated by the intrinsic coagulation cascade. • Pc-conjugated PolyP inhibitors precisely imaged thromboemboli in cerebral stroke mice. Polyphosphate (PolyP) is an emerging target for low-hemorrhagic antithrombotic therapy. However, as an inorganic polymer, PolyP is challenging to target using conventional small-molecule or protein-based drugs. Polyethyleneimine (PEI) and poly- l -lysine (PLL) have been proved to exhibit high efficacy in neutralizing PolyP's procoagulant activity in vitro , but are limited by rapid renal clearance and high toxicity in vivo . We herein chemically modified PEI and PLL with phthalocyanine (Pc), a near-infrared fluorescent compound with strong binding affinity to serum albumin. Modification with Pc firstly extended the in vivo circulation time and duration of antithrombotic effects of PEI and PLL by targeting albumin. Moreover, binding with albumin ameliorated PEI's toxicity both in vitro and in vivo . The antithrombotic activity of these PolyP inhibitors was significantly attenuated in FXI −/− mice, underscoring the dependence of their antithrombotic mechanism on the intrinsic coagulation system. Notably, Pc-PLL localized specifically to thromboemboli in a murine model of cerebral embolic stroke, enabling real-time in vivo thromboembolic imaging. This study proposes a new strategy for the diagnosis and therapy of thrombosis and thromboembolism by targeting PolyP.